Casdin Partners GP, LLC's Form 4 filing
Biolife Solutions Inc (BLFS) · filed May 21, 2026
- Accession no.
- 0000919574-26-003646
- Filed
- May 21, 2026, 7:10 PM ET
- Trade date
- May 19-21, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $28.1M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Casdin Partners GP, LLCCIK 0001534260 | 10% Owner |
| Casdin Capital, LLCCIK 0001534261 | 10% Owner |
| Casdin EliCIK 0001534264 | 10% Owner |
| Casdin Partners Master Fund, L.P.CIK 0001534265 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 19, 2026 | Common Stock, par value $0.001 per share | SSaleDisposed | −300,000 | $22.65 | −$6,795,000 | 5,657,165 | Indirect | |
| May 20, 2026 | Common Stock, par value $0.001 per share | SSaleDisposed | −250,000 | $23.70 | −$5,925,000 | 5,407,165 | Indirect | |
| May 21, 2026 | Common Stock, par value $0.001 per share | SSaleDisposed | −650,000 | $23.70 | −$15,405,000 | 4,757,165 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.